Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR vs Seroquel XR + Lithium in Acute Bipolar Mania
NCT01254721Phase 4Terminated
- Sponsor
- AstraZeneca
- Start
- Dec 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of quetiapine (extended-release tablet, brand name: Bipresso) in bipolar I disorder (2 arms), sponsored by AstraZeneca. Primary endpoint: Young Mania Rating Scale at Day 29. Started Dec 2010; status: terminated.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01254721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01254721.